LRCX

$227.664.79%-11.45

Dopo l'orario di chiusura: 229.17+1.51 +0.66%

Lam Research Corp (LRCX)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$239.11

Aprire:

$243.16

Volume 24 ore:

8,508,725

Volume relativo:

0.65

Capitalizzazione di mercato:

$284.90B

Reddito:

$21.68B

Utile/perdita netta:

$6.71B

Rapporto P/E:

42.97

EPS:

$5.30

Flusso di cassa netto:

$6.00B

1W Prestazione:

-4.14%

1M Prestazione:

-34.48%

6M Prestazione:

-11.32%

1Y Prestazione:

+44.58%

Intervallo 1D:

$224.58$243.56

Intervallo di 1 settimana:

$224.58$260.58

Portata 52W:

$135.50$438.50

Profilo aziendale di Lam Research Corp (LRCX)

Nome

Lam Research Corp

Settore

Technology

Industria

Semiconductor Equipment & Materials

Telefono

(510) 659-0200

Indirizzo

4650 CUSHING BLVD, FREMONT, CA, USA

Dipendente

23,300

@lamresearch

Prossima data di guadagno

null

Ultimi documenti SEC

SEC

Discussioni di LRCX su X

Confronta LRCX con ASML, AMAT, KLAC, TER

Azioni	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LRCX Lam Research Corp	$284.90B	$26.13B	$8.45B	$6.54B	$5.30
ASML Asml Holding Nv	$588.29B	$41.20B	$12.41B	$11.15B	$32.12
AMAT Applied Materials Inc	$297.30B	$30.84B	$9.27B	$5.62B	$10.64
KLAC Kla Corp	$199.56B	$14.51B	$5.26B	$4.04B	$3.54
TER Teradyne Inc	$40.75B	$5.00B	$1.37B	$1.02B	$5.40

Lam Research Corp Azioni (LRCX) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-05-18	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2026-05-05	Iniziato	Seaport Research Partners	Buy
2026-04-02	Downgrade	Erste Group	Buy → Hold
2026-01-29	Aggiornamento	Summit Insights	Hold → Buy
2026-01-29	Reiterato	TD Cowen	Buy
2026-01-15	Iniziato	RBC Capital Mkts	Outperform
2026-01-15	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2025-10-23	Reiterato	TD Cowen	Buy
2025-09-30	Iniziato	HSBC Securities	Hold
2025-09-29	Aggiornamento	Deutsche Bank	Hold → Buy
2025-09-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2025-09-22	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2025-09-02	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2025-08-14	Resumed	Erste Group	Buy
2025-07-31	Downgrade	Summit Insights	Buy → Hold
2025-07-31	Reiterato	TD Cowen	Buy
2025-07-10	Iniziato	Goldman	Buy
2025-04-24	Reiterato	TD Cowen	Buy
2025-03-20	Resumed	Oppenheimer	Outperform
2025-02-20	Aggiornamento	Susquehanna	Neutral → Positive
2025-01-30	Aggiornamento	Bernstein	Mkt Perform → Outperform
2025-01-30	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2025-01-17	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2025-01-15	Downgrade	Wolfe Research	Outperform → Peer Perform
2024-12-17	Iniziato	Cleveland Research	Neutral
2024-08-01	Reiterato	TD Cowen	Buy
2024-05-13	Iniziato	Jefferies	Buy
2024-04-25	Reiterato	TD Cowen	Buy
2024-04-19	Aggiornamento	B. Riley Securities	Neutral → Buy
2024-04-18	Reiterato	Needham	Buy
2024-04-16	Iniziato	Evercore ISI	Outperform
2024-04-11	Resumed	Deutsche Bank	Hold
2024-01-25	Reiterato	TD Cowen	Outperform
2024-01-23	Iniziato	Cantor Fitzgerald	Neutral
2023-12-12	Downgrade	Deutsche Bank	Buy → Hold
2023-12-08	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-11-22	Iniziato	Redburn Atlantic	Buy
2023-10-17	Iniziato	Raymond James	Outperform
2023-10-13	Aggiornamento	Needham	Hold → Buy
2023-09-15	Iniziato	Wolfe Research	Outperform
2023-07-24	Reiterato	Mizuho	Buy
2023-07-24	Aggiornamento	Stifel	Hold → Buy
2023-04-20	Reiterato	Berenberg	Buy
2023-04-20	Reiterato	Evercore ISI	Outperform
2023-04-20	Reiterato	JP Morgan	Overweight
2023-04-20	Reiterato	Jefferies	Buy
2023-04-20	Reiterato	Mizuho	Buy
2023-04-20	Reiterato	Stifel	Hold
2023-04-20	Reiterato	Wells Fargo	Equal Weight
2023-03-13	Downgrade	Bernstein	Outperform → Mkt Perform
2023-01-18	Resumed	Stifel	Hold
2022-12-12	Aggiornamento	Deutsche Bank	Hold → Buy
2022-10-20	Reiterato	B. Riley Securities	Neutral
2022-10-20	Reiterato	BofA Securities	Buy
2022-10-20	Reiterato	DA Davidson	Neutral
2022-10-20	Reiterato	Evercore ISI	Outperform
2022-10-20	Reiterato	JP Morgan	Overweight
2022-10-20	Reiterato	Jefferies	Buy
2022-10-20	Aggiornamento	Summit Insights	Hold → Buy
2022-10-20	Reiterato	Wells Fargo	Equal Weight
2022-07-25	Downgrade	Barclays	Overweight → Equal Weight
2022-06-15	Downgrade	B. Riley Securities	Buy → Neutral
2022-01-27	Reiterato	Barclays	Overweight
2022-01-27	Reiterato	Deutsche Bank	Hold
2022-01-27	Reiterato	Evercore ISI	Outperform
2022-01-27	Reiterato	Stifel	Buy
2022-01-27	Reiterato	Susquehanna	Neutral
2022-01-27	Reiterato	UBS	Buy
2022-01-26	Iniziato	KeyBanc Capital Markets	Sector Weight
2022-01-12	Reiterato	Barclays	Overweight
2022-01-10	Reiterato	BofA Securities	Buy
2022-01-05	Resumed	Jefferies	Buy
2021-12-15	Reiterato	Deutsche Bank	Hold
2021-10-21	Reiterato	B. Riley Securities	Buy
2021-10-21	Downgrade	Summit Insights	Buy → Hold
2021-10-15	Iniziato	Piper Sandler	Neutral
2021-09-14	Downgrade	Susquehanna	Positive → Neutral
2021-09-07	Downgrade	Exane BNP Paribas	Outperform → Neutral
2021-07-29	Reiterato	Mizuho	Buy
2021-07-29	Reiterato	Stifel	Buy
2021-07-29	Reiterato	UBS	Buy
2021-07-29	Reiterato	Wells Fargo	Equal Weight
2021-03-31	Iniziato	Bernstein	Outperform
2021-01-28	Reiterato	Cowen	Outperform
2021-01-08	Downgrade	Needham	Buy → Hold
2020-12-17	Downgrade	Deutsche Bank	Buy → Hold
2020-10-22	Reiterato	Goldman	Buy
2020-10-22	Reiterato	KeyBanc Capital Markets	Overweight
2020-10-22	Reiterato	Mizuho	Buy
2020-10-22	Reiterato	Morgan Stanley	Overweight
2020-10-22	Reiterato	RBC Capital Mkts	Outperform
2020-10-22	Reiterato	Stifel	Buy
2020-10-22	Reiterato	UBS	Buy
2020-09-21	Aggiornamento	Stifel	Hold → Buy
2020-07-30	Reiterato	Cowen	Outperform
2020-07-21	Aggiornamento	B. Riley FBR	Neutral → Buy
2020-06-22	Downgrade	Stifel	Buy → Hold
2020-06-16	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-05-26	Iniziato	Barclays	Overweight
2020-04-23	Reiterato	Needham	Buy
2020-04-08	Iniziato	Exane BNP Paribas	Outperform
2020-04-03	Aggiornamento	Nomura	Neutral → Buy
2020-04-02	Downgrade	DA Davidson	Buy → Neutral
2020-03-27	Aggiornamento	Deutsche Bank	Hold → Buy
2020-03-27	Aggiornamento	UBS	Sell → Buy

Lam Research Corp Azioni (LRCX) Dati Finanziari

Periodo	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Data di fine periodo	2026-06-28	2025-06-29	2024-06-30	2023-06-25	2022-06-26
Revenue USD (M)	23,232.69	18,435.59	14,905.39	17,428.52	17,227.04
Cost of revenue USD (M)	11,507.38	9,456.53	7,852.60	9,651.59	9,355.23
Gross profit USD (M)	11,725.31	8,979.06	7,052.79	7,776.93	7,871.81
Research and development USD (M)	2,375.87	2,096.39	1,902.44	1,727.16	1,604.25
Operating expenses USD (M)	3,525.51	3,078.09	2,788.88	2,602.07	2,489.99
Operating income USD (M)	8,199.80	5,900.97	4,263.91	5,174.86	5,381.82
Income before tax USD (M)	8,262.47	5,958.13	4,360.22	5,109.21	5,193.11
Income tax expense USD (M)	997.08	599.91	532.45	598.28	587.83
Net income USD (M)	7,265.40	5,358.22	3,827.77	4,510.93	4,605.29
Basic EPS USD/shares	5.79	4.17	29.13	33.30	32.92
Diluted EPS USD/shares	5.76	4.15	29.00	33.21	32.75
Basic weighted shares shares (M)	1,255.08	1,286.10	131.41	135.47	139.90
Diluted weighted shares shares (M)	1,261.10	1,290.14	132.00	135.83	140.63
Selling, general and administrative USD (M)	1,149.64	981.70	868.25	832.75	885.74

Lam Research Corp Azioni (LRCX) insider trading

Mayer BethanyNov 02 '26
Director
Transazione
Proposed Sale
Costo
$242.59
#Azioni
719
Valore ($)
174,422
#Azioni Totale
0
ARCHER TIMOTHYOct 23 '26
President and CEO
Transazione
Sale
Costo
$227.02
#Azioni
31,400
Valore ($)
7,128,428
#Azioni Totale
1,075,966
ARCHER TIMOTHYOct 23 '26
President and CEO
Transazione
Option Exercise
Costo
$30.03
#Azioni
31,400
Valore ($)
943,036
#Azioni Totale
1,107,366
ARCHER TIMOTHYOct 23 '26
Officer
Transazione
Proposed Sale
Costo
$227.02
#Azioni
31,400
Valore ($)
7,128,428
#Azioni Totale
0
ARCHER TIMOTHYSep 09 '26
President and CEO
Transazione
Sale
Costo
$319.26
#Azioni
30,000
Valore ($)
9,577,800
#Azioni Totale
1,075,966
ARCHER TIMOTHYSep 09 '26
Officer
Transazione
Proposed Sale
Costo
$319.26
#Azioni
30,000
Valore ($)
9,577,800
#Azioni Totale
0
ARCHER TIMOTHYSep 09 '26
President and CEO
Transazione
Option Exercise
Costo
$30.03
#Azioni
30,000
Valore ($)
900,990
#Azioni Totale
1,105,966
BETHANY MAYERSep 09 '26
Director
Transazione
Proposed Sale
Costo
$314.74
#Azioni
9,557
Valore ($)
3,007,970
#Azioni Totale
0
Mayer BethanySep 09 '26
Director
Transazione
Sale
Costo
$314.74
#Azioni
9,557
Valore ($)
3,007,970
#Azioni Totale
20,995
Varadarajan SeshasayeeSep 02 '26
Officer
Transazione
Proposed Sale
Costo
$291.32
#Azioni
59,750
Valore ($)
17,406,370
#Azioni Totale
0

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Mayer Bethany	Director	Nov 02 '26	Proposed Sale	$242.59	719	174,422	0
ARCHER TIMOTHY	President and CEO	Oct 23 '26	Sale	$227.02	31,400	7,128,428	1,075,966
ARCHER TIMOTHY	President and CEO	Oct 23 '26	Option Exercise	$30.03	31,400	943,036	1,107,366
ARCHER TIMOTHY	Officer	Oct 23 '26	Proposed Sale	$227.02	31,400	7,128,428	0
ARCHER TIMOTHY	President and CEO	Sep 09 '26	Sale	$319.26	30,000	9,577,800	1,075,966
ARCHER TIMOTHY	Officer	Sep 09 '26	Proposed Sale	$319.26	30,000	9,577,800	0
ARCHER TIMOTHY	President and CEO	Sep 09 '26	Option Exercise	$30.03	30,000	900,990	1,105,966
BETHANY MAYER	Director	Sep 09 '26	Proposed Sale	$314.74	9,557	3,007,970	0
Mayer Bethany	Director	Sep 09 '26	Sale	$314.74	9,557	3,007,970	20,995
Varadarajan Seshasayee	Officer	Sep 02 '26	Proposed Sale	$291.32	59,750	17,406,370	0

Lam Research Corp Borsa (LRCX) Ultime notizie

Nov 02, 2026

What UCTT's Q3 Beat and Strong Q4 Guidance Mean for Investors Now - Zacks Investment Research

Nov 02, 2026

Is UCTT Worth Buying as Growth Accelerates but Cash Flow Weakens? - Zacks Investment Research

Nov 02, 2026

UCTT Fell 31.6% in the Past Month: Is the Sell-Off an Opportunity? - Zacks Investment Research

Nov 02, 2026

Oct 31, 2026

Jim Cramer Likes Lam Research but Says Buy Just 25% of Your Position - Yahoo Finance

Oct 31, 2026

LAM RESEARCH CORP (NASDAQ:LRCX): Affordable Growth at a Reasonable Valuation - ChartMill

Oct 31, 2026

Oct 30, 2026